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Early interactions of herpes simplex virus type-1 (HSV-1) with cells lead to cytoskeletal changes
facilitating filopodia formation and membrane fusion. Here, we demonstrate that phosphoinositide
3 kinase (PI3K) signalling may affect multiple steps during HSV-1 entry. An inhibitor of PI3K
(LY294002) blocked HSV-1 entry and the blockage was cell-type- and gD receptor-
independent. Entry inhibition was also observed with primary cultures of the human corneal
fibroblasts and unrelated b- and c-herpesviruses. Immunofluorescence analysis demonstrated that
LY294002 negatively affected HSV-1-induced filopodia formation. Similar effects of the inhibitor
were seen on HSV-1 glycoprotein-induced cell-to-cell fusion. Cells expressing HSV-1
glycoproteins (gB, gD, gH and gL) showed significantly less fusion with target cells in the
presence of the inhibitor. Expression of a dominant-negative PI3K mutant negatively affected both
entry and fusion. We also show that inhibition of PI3K signalling also affected RhoA activation
required for HSV-1 entry into certain cell types.
Herpes simplex virus type-1 (HSV-1) is a ubiquitous
human virus, commonly associated with the outbreaks of
facial cold sores. Recurrent infections in the eye can cause
corneal blindness (Farooq et al., 2010). Severe complica-
tions especially in neonates and immunocompromised
patients may result in retinitis and inflammation of the
brain tissues that leads to encephalitis (Liesegang et al.,
1989; reviewed by Liesegang, 2001; Roizman & Sears, 1996;
Whitley et al., 1998). HSV-1 infects host cells through
initial attachment to cells via surface heparan sulfate (HS)
followed by fusion of the virion envelope with the plasma
membrane (Shukla & Spear, 2001; Spear et al., 2000). The
current model suggests that entry of virus requires four
HSV glycoproteins (gB, gD, gH and gL) (Browne et al.,
2001; Davis-Poynter et al., 1994; Forrester et al., 1992;
Muggeridge, 2000; Pertel et al., 2001; Turner et al., 1998)
and at least one cellular receptor for gD (Cocchi et al.,
2000; Terry-Allison et al., 2001; Tiwari et al., 2004). The
receptors for HSV-1 gD include a member of the tumour
necrosis factor-receptor family named herpesvirus entry
mediator (HVEM) (Montgomery et al., 1996; Tiwari et al.,
2005a), a member of the immunoglobulin superfamily
commonly known as nectin-1 (Cocchi et al., 1998; Shukla
et al., 2006) and modifications in HS by multiple D-
glucosaminyl 3-O-sulfotransferase (3-OST) isoforms. Among
the known 3-OST isoforms, all but one (3-OST-1) isoforms
mediate HSV-1 entry (O’Donnell et al., 2006; Shukla et al.,
1999; Tiwari et al.,2 0 0 5 b ;X i aet al., 2002; Xu et al., 2005) and
cell-to-cell fusion (O’Donnell & Shukla, 2009; Tiwari et al.,
2004). It has also been proposed that paired immunoglobu-
lin-like receptor alpha can serve as a co-receptor for HSV-1 by
interaction with glycoprotein B (gB) (Satoh et al., 2008;
Shukla et al., 2009).
HSV can also induce host cell cytoskeletal rearrangements
to facilitate infection (Akhtar & Shukla, 2009). In this
regard, HSV-1 entry and cell-to-cell spread may particu-
larly be benefitted by changes in cytoskeletal rearrange-
ments (Farooq et al., 2010; Tiwari et al., 2008). For
instance, cytoskeletal elements such as actin filaments may
be reorganized in parallel bundles to form filopodia for
viral surfing/transport to reach the cell body (O’Donnell &
Shukla, 2008; Oh et al., 2010). Similarly, alterations in
cytoskeleton may be needed when membranes fuse during
HSV-1 entry or cell-to-cell spread (Spear et al., 2000;
O’Donnell et al., 2010). In addition, HSV-1 also utilizes
microtubules for transport from the cell periphery towards
the nucleus (Marozin et al., 2004).
Recent studies have shown that HSV-1 relies heavily on
actin cytoskeleton during phagoctyic-uptake by primary
cultures of human corneal fibroblasts (CF) and for surfing
in retinal pigment epithelial (RPE) cells (Clement et al.,
2006; Tiwari et al., 2008). Induction of filopodia formation
provides a unique large surface area for virus to surf and
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entry activates Rho-GTPase signalling pathways within a
target cell that helps facilitate viral entry (Clement et al.,
2006; Oh et al., 2010). It has been previously shown that
Rho-GTPases (Rho-A and cdc42) are key modulators that
facilitate filopodia formation during viral entry (Clement
et al., 2006). One downstream signalling pathway for
filopodia-induction is phosphoinositide 3 kinase (PI3K)
(Greber, 2002). PI3Ks are a cellular family of heterodimeric
enzymes that consist of a regulatory subunit (p85)
activated by tyrosine phosphorylation, which recruits
inositol phospholipids that are phosphorylated by the
catalytic subunit (p110) (Carpenter et al., 1993; Hiles et al.,
1992; Skolnik et al., 1991; Stoyanov et al., 1995). These
lipids serve as second messengers that regulate the
phosphorylation of other kinases such as Akt/PKB, cyclic
AMP-dependent protein kinase A, some protein kinase C
isoforms, and the ribosomal S6 kinases p70 and p85
(Coffer et al., 1998). The ability of PI3K to regulate
multiple cellular pathways, coupled with the need for HSV
to induce an environment favourable for viral entry via
changes in actin cytoskeleton in host cells, prompted us to
examine the role of PI3K signalling in HSV-1 entry into
natural target cells from the human eye (Farooq et al.,
2010). Our study demonstrates that PI3K activity is
exploited by HSV-1 during filopodia induction and also
during cell-to-cell fusion.
We began our study using HeLa, RPE and primary cultures
of CF isolated from the stroma of human cornea (obtained
from the Illinois Eye Bank, Chicago, IL, USA; processed by
using the institution approved protocol in accordance with
the Declaration of Helsinki). Human CF is a natural target
cell type that has been shown to exploit 3-O-sulfated
heparan sulfate as a receptor (Tiwari et al., 2006, 2007).
RPE cells also get infected during a natural infection and
virus entry is mediated by nectin-1 receptor (Tiwari et al.,
2008). Cultures of CF were grown in L-glutamine contain-
ing minimum essential medium (MEM; Invitrogen)
supplemented with 10% FBS (Sigma) and 5% calf serum
(CS) as described previously (Yue & Baum, 1981). The
transformed HeLa and RPE cells were grown in Dulbecco’s
modified Eagle medium (Invitrogen) containing 10% FBS
as described previously (Tiwari et al., 2008). The cells were
trypsinized and passaged after reaching confluency. CFs
from third passages were used for this study.
To determine the effect of the PI3K inhibitor (LY294002;
Cell Signaling Technology) on HSV-1 entry, we first tested
the ability of HSV-1 to infect cells in the presence and
absence of LY294002. The inhibitor is stable at 37 uC and
an extremely potent and specific inhibitor of PI3K activity
(King et al., 1997; Wennstrom & Downward, 1999). HSV-1
entry into the cell was determined by using b-galactosi-
dase-expressing HSV-1 reporter virus (KOS gL86). As
shown in Fig. 1, the PI3K inhibitor significantly blocked
viral entry in a dose-dependent manner in RPE, HeLa and
CF cells. The blocking activity of the PI3K inhibitor was seen
at concentrations as low as 0.05 mM as well. Interestingly,
either pre-treatment of HSV-1 with the PI3K inhibitor
or pre-treatment of cells showed similar results. This is
probably not due to any virucidal effects of the inhibitor. Its
well sustained cellular kinase inhibition activity is probably
responsible for the inhibition of entry. The net concentra-
tion of the inhibitor does not change in either case as it has a
relatively long half-life (3.5210.0 h) (Gervais et al., 2006;
Jones et al., 1999), which may cause the inhibitor to remain
effective on cells regardless of whether the virus or the cells
were treated first. The negative effect on entry was not
associated with any particular gD receptor since the effect
was repeatedly observed with each gD receptor expressed
alone in Chinese hamster ovary (CHO-K1) cells (Fig. 1d),
which do not normally express them (Shukla et al., 1999).
We also evaluated whether the effect is limited to HSV-1
(KOS) strain or if other HSV-1 strains would also be
negatively affected by the inhibitor. Nectin-1 expressing
CHO Ig8 cells that express b-galactosidase upon viral entry
(Montgomery et al., 1996) were used to examine additional
virulent strains of HSV-1 (F, MP and 17) (Dean et al., 1994).
The cells were pre-incubated with the PI3K inhibitor and
then infected with various HSV-1 strains. The results from
this experiment again showed that the inhibitor blocks entry
of all HSV-1 strains in a dose-dependent manner (Fig. 1e).
Next, to demonstrate that the inhibitory effect of LY294002
on HSV-1 entry was specific, we used a highly related
compound LY303511 (Calbiochem Inc.) that does not affect
PI3K activity. As shown in Fig. 1(f) the inactive compound
had no effect on HSV-1 entry, while LY294002 significantly
affected HSV-1 entry. A more potent PI3K signalling
inhibitor wortmanin has also been shown to inhibit HSV-
1 transport (Nicola & Straus, 2004). At this point we did not
rule out that the effects seen on entry could have also been
due to the inhibition of the capsid transport. The signifi-
cance of PI3K signalling during HSV-1 entry was further
ascertained by overexpressing a dominant-negative PI3K
mutant lacking the p110-catalytic subunit-binding domain
(DiSH2) (Ueki et al., 2000). This mutant significantly
reduced viral entry into the cells (Fig. 1g), suggesting once
again an important role for PI3K in HSV-1 entry.
We next investigated other herpesviruses and their
dependence on PI3K signalling during entry. As shown in
Fig. 2(a)–(c), pre-treatment of natural target cells with the
PI3K inhibitor significantly reduced the entry of HSV-1
(a-herpesvirus), cytomegalovirus (CMV, Towne strain;
b-herpesvirus) and human herpes virus-8 (HHV-8;
c-herpesvirus), suggesting that the effect of PI3K signalling
may be universal among herpesviruses.
Further, to gain an understanding of the specific effects of
the PI3K inhibitor, we asked whether the inhibitor can
affect HSV-1-induced filopodia formation (Oh et al.,
2010). To answer this question, immunofluorescence was
used to stain wild-type HSV-1 (KOS)-infected HeLa and
RPE cells in the presence and the absence of the inhibitor.
As shown in Fig. 2(d) and (e), HSV-1 failed to induce
filopodia in both types of cells pre-incubated with the PI3K
inhibitor. This probably affects the entry, since the inability
PI3K signalling is required for HSV-1 entry
http://vir.sgmjournals.org 3003Fig. 1. PI3KinhibitornegativelyaffectsHSV-1entry.(a–c)Dose-dependenteffectofLY294002onHSV-1entryintonaturaltarget
cells. Experiments were performed in two different ways. As indicated either virus or target cells (RPE, HeLa or CF) were first pre-
incubated with the PI3K inhibitor (LY294002) at stated concentrations for 90 min in 96-well plate dishes at room temperature
followed by the addition of recombinant HSV-1 (gL86 virus at 40 p.f.u. per cell). After 2 h, cells were washed with 1 PBS and
incubated in the culture medium for an additional 4 h. Finally, the cells were permeabilized and incubated with O-nitrophenyl-b-D-
galactopyranoside (ONPG) substrate for the quantification of b-galactosidase activity expressed from the input viral genome. The
enzymic activity was measured (Spectra Max 190; Molecular Devices) at an optical density of 410 nm. (d) PI3K signalling during
HSV-1 entry is not gD receptor specific. CHO-K1 cells transiently expressing gD receptors: nectin-1, HVEM and 3-OST-3 were
pre-treatedwithLY294002for45 minfollowedbyinfectionwiththerecombinantHSV-1(KOS)gL86virus(40p.f.u.percell).After
6 h, entry was measured as described above (a–c). In this and other figures each value shown is the mean of three or more
determinations (±SD). (e) PI3K inhibitor also inhibits entry of additional wild-type strains of HSV-1. CHO Ig8 cells that express b-
galactosidase upon viral entry were pre-incubated with 1 PBS (control) or with the PI3K inhibitor (LY294002) at indicated
concentrations for 45 min at room temperature. After 45 min, HSV-1 (F, MP or 17 at 50 p.f.u. per cell) were incubated with the
cells. Viral entry blocking was measured as described above (a–c). (f) The inactive compound LY303511 has no effect on HSV-1
entry.ThetargetCFcells were firstpre-incubatedwithLY303511 orwithLY294002at0.05 mMconcentrationsfor90 min in96-
well plate dishes at room temperature followed by the addition of recombinant HSV-1 (gL86 virus at 40 p.f.u. per cell). After 6 h,
entry was measured as described above (a–c). (g) Over expression of PI3K dominant-negative in CF cells significantly affects
HSV-1entry.CFsweretransfectedwithPI3Kdominant-negativeexpressionplasmid(DiSH2)(Uekietal.,2000)oremptyvectorat
2.5 mg DNA. About 18 h post-transfection, cells were infected with HSV-1 KOS (gL86) and 6 h later entry was measured as
described above (a–c). Each value shown is the mean of three or more determinations (±SD).
V. Tiwari and D. Shukla
3004 Journal of General Virology 91of cells to form filopodia has been shown to result in
significant reduction of virus infectivity (Oh et al., 2010).
Finally, we tested the role of PI3K signalling during HSV-1
glycoproteins-mediated cell-to-cell fusion. Cell fusion has
been used to demonstrate viral and cellular requirements
during entry and spread (Pertel et al., 2001). Quite
evidently, target cells expressing individual HSV-1 gD
receptor nectin-1, HVEM and 3-OST-3 treated with the
PI3K inhibitor demonstrated impaired cell-to-cell fusion
with effector cells expressing four HSV-1 (KOS) glycopro-
teins, gB (pPEP98), gD (pPEP99), gH (pPEP100) and gL
Fig. 2. PI3K inhibitor blocks filopodia formation and entry of additional herepesviruses into target cells. (a–c) Inhibition of PI3K
signalling pathway also affects other members of herpesvirus family. a [HSV-1; (a)], b [CMV; (b)] and c [HHV-8; (c)] were
examined. CF, RPE and human conjunctival epithelium (HCE) were pre-incubated with the PI3K inhibitor LY294002 at 0.5 mM
for 90 min in 96-well plate dishes at room temperature followed by challenge with b-galactosidase expressing recombinant
HSV-1 (HeLa cells) and CMV (RPE cells) and GFP-expressing HHV-8 (HCE cells). HCE cells were grown and cultured as
previously described by us (Akhtar et al., 2008). b-Galactosidase activity was determined as described in Fig. 1. For HHV-8-
mediated entry, fluorescence intensity was measured 2 days post-infection (Clement et al., 2006). Data represent the
mean±SD of results in triplicate wells in a representative experiment. The experiment was repeated three times with similar
results. (d, e) PI3K inhibitor significantly affects filopodia formation. In this experiment, F-actin staining was performed on HeLa
(d) and RPE (e) cells in various combinations as indicated. Either cells or the virus (KOS) were pre-treated with LY294002.
After 90 min of infection, cells were fixed and stained for F-actin using 10 nM rhodmaine-conjugated phalloidin (Molecular
Probes) dissolved in 1 PBS for 45 min at room temperature. After three washes, cells were mounted on the slides using
Vectashield. All the images were captured on confocal microscopy (Leica SP2) with 63 objective.
PI3K signalling is required for HSV-1 entry
http://vir.sgmjournals.org 3005Fig. 3. PI3K signalling is critical during HSV-1 glycoprotein-mediated cell-to-cell fusion and filopodia formation. (a, b)
LY294002 blocks cell-to-cell fusion. Target cells expressing HSV-1 gD receptor (indicated) were either treated with the PI3K
inhibitor (0.5 mM) or not treated and then incubated with effector cells expressing HSV-1 (KOS) glycoproteins, gB, gD, gH and
gL. A luciferase-based reporter system was used to measure fusion (all plasmids and the assay are described by Pertel et al.,
2001). Relative luciferase activity was measured in relative luciferase units (RLU) (y-axis). (b) Cell fusion was confirmed using a
fluorescent-labelled cell fusion assay in which nectin-1 expressing target CHO-K1 cells co-transfected with pDSRed N1
fluorescent plasmid and either untreated (i) or highlighted (ii) or treated with PI3K inhibitor (iii) or highlighted (iv) were co-
incubated with effector CHO-K1 cells co-transfected with HSV-1 glycoprotein (gB, gD and gH–gL) and a GFP-expressing
plasmid. (c) Inhibition of PI3K signalling prevents RhoA activation by HSV-1 in CF. Western blot analysis shows the inhibition of
RhoA in the presence of PI3K inhibitor. Primary cultures of human CF were treated with the PI3K inhibitor or mock treated for
30 min followed by HSV-1 (50 p.f.u. per cell) infection for 15 min. RhoA activation was determined by using Rhotekin-RBD-
GST (RhoA) kit using manufacturer’s protocol (Cytoskeleton Inc.). (d) A structural homologue, LY303511, shows no effect on
HSV-1 glycoprotein-induced cell fusion. The target CF cells expressing luciferase reporter gene were treated with or without
LY303511 (0.05 mM) before co-culture with the effector cells expressing HSV-1 glycoproteins gB, gD, gH, gL and T7 RNA
polymerase. A luciferase reporter assay was performed 18 h after the two cell populations were mixed together. Cell fusion was
measured in relative luciferase units (RLU) using a Sirius luminometer (Berthold Detection System). The data shown are the
means of triplicate measures and are representative of three independent experiments. (e) Over expression of dominant-
negative PI3K significantly inhibits HSV-1 glycoprotein-induced cell fusion. The target CF cells were transfected either with
PI3K dominant-negative expression plasmid (DiSH2) or with control plasmid, and luciferase reporter gene. The effector cells
were transfected with HSV-1 glycoproteins gB, gD, gH, gL and T7 RNA polymerase. A luciferase reporter assay was performed
18 h after the two cell populations were mixed together. Cell fusion was measured in relative luciferase units (RLU) as
described above. The data shown are the means of triplicate measures and are representative of three independent
experiments.
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(Fig. 3a). This response was further confirmed by using a
fluorescent-labelled cell fusion assay (Fig. 3b). Nectin-1-
expressing target CHO-K1 cells co-transfected with
pDSRed N1 fluorescent plasmid incubated with the PI3K
inhibitor for 60 min failed to fuse with the effector CHO-
K1 cells co-transfected with HSV-1 glycoprotein (gB, gD
and gH–gL) and a GFP-expression plasmid [Fig. 3b(iii)].I n
contrast, the control (untreated) effector red cells fused
(yellow colour) with green target cells [Fig. 3b(i)]. Our
result also shows the presence of filopodia on effector cells
during cell fusion in the absence of inhibitor. It is clear that
the inhibitor treatment not only blocks the cell fusion, but
also negatively affects the induction of filopodia formation.
Finally, we rationalized that if PI3K regulates actin
networks and induction of filopodia formation in HSV-
1-infected cells then RhoA activation in human CF may
also be affected by the inhibitor. This would be observed
especially when PI3K is required upstream of RhoA
activation. Our previous studies have shown that RhoA
plays a critical role during phagoctyic uptake of HSV-1 by
primary human CF (Clement et al., 2006) and likewise, it
has been suggested that PI3K is involved in integrin-
mediated signalling pathway that leads to the induction of
filopodia (Chang et al., 2005). As shown in Fig. 3(c), pre-
treatment of human CF with the PI3K inhibitor signifi-
cantly reduced RhoA activation, which may also be a reason
why HSV-1 activity is adversely affected by the inhibitor.
The inhibitor blocks PI3K activity and RhoA activation by
the virus may be downstream from it. The effect of the
inhibitor on fusion was specific, since a highly related but
inactive compound LY303511 (Calbiochem Inc.) had no
significant effect on HSV-1 glycoprotein-induced cell fusion
with target CF cells (Fig. 3d). In addition, expression
of the dominant-negative PI3K mutant (DiSH2) (Ueki
et al., 2000) in target CF cells also inhibited HSV-1
glycoprotein-induced cell fusion (Fig. 3e). Collectively,
our results suggest an important role for PI3K in membrane
fusion.
The role of actin cytoskeleton is widely implicated in
microbial pathogenesis (Dohner & Sodeik, 2005; Greber &
Way, 2006; Marsh & Helenius, 2006). Multiple viruses
exploit the host actin cytoskeleton to facilitate important
aspects of their life cycles including entry into target cell,
egress and intercellular spread (Radtke et al., 2006). Recent
findings indicate that murine leukemia virus (MLV),
African swine fever virus and human papillomavirus use
filopodia to infect cells (Jouvenet, et al., 2006; Lehmann
et al., 2005; Sherer et al., 2007; Smith et al., 2008).
Similarly, Kaposi’s sarcoma herpes virus enhances filopodia
formation (Veettil et al., 2006). Even before entering into
cells, viruses interact with the actin cytoskeleton in a
number of ways. Recent live-cell imaging results have
demonstrated a role for the actin cytoskeleton in virus
entry via the process of ‘surfing’. In this process the
retroviruses, MLV and avian leukosis virus, as well as
vesicular stomatitis virus, were shown to associate with the
dense microvilli and/or filopodia of polarized epithelia and
move on to the cell surface in an actin- and myosin-
dependent manner prior to internalization (Lehmann
et al., 2005; Sherer et al., 2007). Others have shown that
blockage of PI3K signalling induced by additional viruses
such as human immunodeficiency virus inhibits viral
infection (Franc ¸ois & Klotman, 2003). Thus, PI3K signal-
ling and its downstream effectors may play a vital role in
supporting virus infections in general (Dimitrov, 2004;
Sieczkarski & Whittaker, 2005). Our study opens the door
for future studies analysing specific viral and cellular
mediators of PI3K activation by HSV-1. Knowledge of such
specific mediators is likely to open up new ways to develop
anti-herpesvirus agents and strategies.
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